[Experience in using and an assessment of the clinical effectiveness of the kallikrein-protease inhibitor kontrikal in the combined therapy of ischemic heart disease].
D007611:Aprotinin / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D012008:Recurrence; D012770:Shock, Cardiogenic / Q000188:drug therapy; D013997:Time Factors
D007611:Aprotinin
Opyt primeneniia i otsenka klinicheskoĭ éffektivnosti kallikrein-proteaznogo ingibitora kontrikala v kompleksnoĭ terapii ishemicheskoĭ bolezni serdtsa.